; or (bb) the National Institutes of Health or another Federal agency that funds scientific research; or (II) in the case of nonhuman research that is not federally funded, has been voluntarily submitted by the applicant to, and approved by, the National Institutes of Health; and (iv) the applicant has demonstrated that there are effective procedures in place to adequately safeguard against diversion of the marijuana from legitimate medical or scientific use, in accordance with subparagraph (E). (B) The Attorney General shall grant an application for registration under this paragraph unless the Attorney General determines that the issuance of the registration would be inconsistent with the public interest. In determining the public interest, the following factors shall be considered: (i) The applicant’s experience in dispensing, or conducting research with respect to, controlled substances. (ii) The applicant’s conviction record under Federal or State laws relating to the manufacture, distribution, or dispensing of controlled substances. (iii) Compliance with applicable State or local laws relating to controlled substance misuse or diversion. (C) Not later than 90 days after the date of enactment of the Medical Marijuana Research Act of 2017 , for purposes of subparagraph (A)(ii)(II), the National Institutes of Health shall establish a process that— (i) allows a researcher to voluntarily submit the research protocol of the researcher for review and approval